Univest
Univest
  • Markets

Nifty Pharma Prediction for Monday: 21 September 2026 Outlook (Including F&O)

  • September 18, 2026
  • Posted by: Harsh Piplani
  • Category: Uncategorized
No Comments
Nifty Pharma Prediction for Monday: 21 September 2026 Outlook (Including F&O)

Click Here – Get Free Investment Predictions

The nifty pharma prediction for monday here is built from Friday’s closing prices, not speculation about what Monday will bring.

Table of Contents

Toggle
  • Nifty Pharma Prediction for Monday: 21 September 2026 Outlook (Including F&O)
    • Today’s Sector Recap
    • Nifty Pharma F&O Outlook for Monday
    • Key Drivers for Monday
    • Stocks to Watch for Monday
    • Risks to This Prediction
    • Conclusion
    • FAQs
      • What is the nifty pharma prediction for monday?
      • Which stocks matter most for this sector’s outlook on Monday?
      • Why did Nifty Pharma rise despite Sun Pharma’s fall?
      • Should traders take F&O positions based on this outlook?

Nifty Pharma Prediction for Monday: 21 September 2026 Outlook (Including F&O)

Nifty Pharma closed at 26,710.10, up 0.49%. Sun Pharmaceutical Industries fell 1.61%. India VIX 11.42.

Quick Answer: The nifty pharma prediction for monday is cautious to sideways for 21 September 2026. Sun Pharmaceutical Industries, a key constituent, fell 1.61 percent on 18 September 2026, tracking broader Nifty 50 direction and F&O positioning.

The nifty pharma prediction for monday is in focus after Nifty Pharma closed at 26,710.10 on 18 September 2026, up 0.49 percent. Pharma stocks gained today even as sun pharma itself eased, with apollo hospitals offsetting that weakness

Anyone acting on this nifty pharma prediction for monday should still size positions around their own comfort with risk, not just the levels above.

Ankit Jaiswal, Senior Research Analyst at Univest, and Kunal Singla, Associate Director at Univest, are watching sector-specific triggers here, alongside the broader Nifty 50 and Sensex direction heading into 21 September 2026.

Also read – Stock Market Prediction for Monday, 21 September 2026

Today’s Sector Recap

  • Sun Pharmaceutical Industries fell 1.61 percent, among the key movers in this space on 18 September 2026.
  • The broader Nifty 50 closed at 23,346.40, up 0.23 percent, setting a cautious tone across most sectors.
  • India VIX rose to 11.42, indicating a mild pickup in near-term volatility expectations.

This nifty pharma prediction for monday leans on Friday’s numbers because that’s the last real data available before trading resumes after the weekend.

Nifty Pharma F&O Outlook for Monday

For traders active in F&O, this outlook will hinge on open interest build-up and rollover activity in Nifty Pharma futures and options contracts into 21 September 2026. Kunal Singla notes that a stable to falling India VIX would support range-bound F&O positioning, while a further rise could see wider intraday swings.

Key Drivers for Monday

  • Pharma stocks gained today even as sun pharma itself eased, with apollo hospitals offsetting that weakness
  • Crude oil eased modestly, down about half a percent on mcx, a third straight session of softer prices as the earlier risk premium continues to unwind, a theme weighing on broader market sentiment.
  • India vix fell sharply for a second straight session, down 7.08 percent on top of thursday’s 7.82 percent drop, while hdfc bank’s 2.52 percent rally offset a sharp 3.88 percent fall in tcs that extended it’s difficult week.

Stocks to Watch for Monday

Stock CMP Relevance
Sun Pharmaceutical Industries See Univest Screener Key Nifty Pharma constituent
Apollo Hospitals Enterprise See Univest Screener Additional Nifty Pharma name to track

Explore Nifty Pharma Stocks on Univest Screeners

None of this nifty pharma prediction for monday is a guarantee. Markets that calm down quickly can turn just as quickly.

Risks to This Prediction

  • A sharper than expected move in crude oil prices could shift sentiment across all sectors, including Nifty Pharma.
  • Stock-specific news flow in Sun Pharmaceutical Industries or other constituents could override the broader sector trend.
  • A spike in India VIX could widen intraday ranges beyond the levels discussed here.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Conclusion

The nifty pharma prediction for monday leans cautious to sideways into 21 September 2026, with Sun Pharmaceutical Industries and broader Nifty 50 direction as the key variables. Ankit Jaiswal and Kunal Singla will revisit this view once Monday’s opening trade confirms direction.

Treat this nifty pharma prediction for monday as a working view. It will get revisited fast if Monday’s opening trade says otherwise.

Also read – Nifty 50 Prediction for Monday, 21 September 2026

Disclaimer: Investments and trades in securities and commodities are subject to market risk. Read all related documents carefully before investing. The information provided here is for educational purposes only and does not constitute investment advice. Univest is a SEBI-registered investment adviser (Registration No. INH000013776). Past performance is not indicative of future returns.

FAQs

What is the nifty pharma prediction for monday?

Ans. It is cautious to sideways, based on Sun Pharmaceutical Industries’s fall of 1.61 percent on 18 September 2026 and the broader Nifty 50 trend.

That’s the core of this nifty pharma prediction for monday: a session with real cross-currents, not a one-way move.

Which stocks matter most for this sector’s outlook on Monday?

Ans. Sun Pharmaceutical Industries is one of the key stocks to track, along with the broader Nifty 50 and Sensex direction.

Why did Nifty Pharma rise despite Sun Pharma’s fall?

Ans. Nifty Pharma rose 0.49 percent today despite Sun Pharma’s 1.61 percent decline, as Apollo Hospitals’ 2.01 percent gain offset that weakness.

Should traders take F&O positions based on this outlook?

Ans. Any F&O position based on this outlook should factor in position sizing and stop-loss discipline, given the current uptick in India VIX.



Nifty Pharma
Author: Harsh Piplani
I am Harsh Piplani, an Assistant Content Manager with over 5 years of experience in crafting impactful, result-driven content. I hold a B.Com (Hons) degree and have worked across diverse industries, including education, fintech, healthcare, jewellery, and more. I specialise in content strategy, SEO, and optimisation, ensuring that every piece I create is not just well-written but also well-ranked. I believe content should do more than fill space so as to drive traffic, build authority, and support business growth. I enjoy turning complex ideas into clear, engaging narratives, and, as I like to say, I know how to spin words like a web to influence, structured, strategic, and impossible to ignore. For me, great content sits at the intersection of creativity and performance.

Leave a Reply Cancel reply